Somatic mutations are frequently detected in CML patients
before treatment-free remission (TFR) attempt with tyrosine
kinase inhibitor (TKI) discontinuation but with uncertain
predictive valu efor Tfr failure

a 2022

Somatic mutations are frequently detected in CML patients before treatment-free remission (TFR) attempt with tyrosine kinase inhibitor (TKI) discontinuation but with uncertain predictive valu efor Tfr failure

PERUSINI, MA., K. PAGNANO, C. PAVLOVSKY, K. PAGNANO, B. MOIRAGHI et. al.

Basic information

Original name

Somatic mutations are frequently detected in CML patients before treatment-free remission (TFR) attempt with tyrosine kinase inhibitor (TKI) discontinuation but with uncertain predictive valu efor Tfr failure

Authors

Edition

64th ASH Annual Meeting and Exposition, USA, New Orleans, prosinec 2022 in Blood, 2022

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Faculty of Medicine

Změněno: 21/12/2022 09:16, Bc. Kateřina Kolesová

Citovat

PERUSINI, MA., K. PAGNANO, C. PAVLOVSKY, K. PAGNANO, B. MOIRAGHI, AI. VARELA, M. BIANCHINI, Jiří MAYER, Daniela ŽÁČKOVÁ, Anežka KVETKOVÁ, Tomáš JURČEK, Ivana JEŽÍŠKOVÁ, ABP. LOPES, G. DUARTE, CA. SOUZA, J. MEDEIROS, TS. KIM, YS. YOO, KH. KIM, HW. LEE, MH. CHANG, SY. YI, S. ABELSON and D. KIM. Somatic mutations are frequently detected in CML patients before treatment-free remission (TFR) attempt with tyrosine kinase inhibitor (TKI) discontinuation but with uncertain predictive valu efor Tfr failure. In 64th ASH Annual Meeting and Exposition, USA, New Orleans, prosinec 2022 in Blood. 2022.

@proceedings{2241222,
   author = {Perusini, MA. and Pagnano, K. and Pavlovsky, C. and Pagnano, K. and Moiraghi, B. and Varela, AI. and Bianchini, M. and Mayer, Jiří and Žáčková, Daniela and Kvetková, Anežka and Jurček, Tomáš and Ježíšková, Ivana and Lopes, ABP. and Duarte, G. and Souza, CA. and Medeiros, J. and Kim, TS. and Yoo, YS. and Kim, KH. and Lee, HW. and Chang, MH. and Yi, SY. and Abelson, S. and Kim, D.},
   booktitle = {64th ASH Annual Meeting and Exposition, USA, New Orleans, prosinec 2022 in Blood},
   title = {Somatic mutations are frequently detected in CML patients before treatment-free remission (TFR) attempt with tyrosine kinase inhibitor (TKI) discontinuation but with uncertain predictive valu efor Tfr failure},
   year = {2022}
}

TY  - CONF
ID  - 2241222
AU  - Perusini, MA. - Pagnano, K. - Pavlovsky, C. - Pagnano, K. - Moiraghi, B. - Varela, AI. - Bianchini, M. - Mayer, Jiří - Žáčková, Daniela - Kvetková, Anežka - Jurček, Tomáš - Ježíšková, Ivana - Lopes, ABP. - Duarte, G. - Souza, CA. - Medeiros, J. - Kim, TS. - Yoo, YS. - Kim, KH. - Lee, HW. - Chang, MH. - Yi, SY. - Abelson, S. - Kim, D.
PY  - 2022
TI  - Somatic mutations are frequently detected in CML patients before treatment-free remission (TFR) attempt with tyrosine kinase inhibitor (TKI) discontinuation but with uncertain predictive valu efor Tfr failure
ER  -

PERUSINI, MA., K. PAGNANO, C. PAVLOVSKY, K. PAGNANO, B. MOIRAGHI, AI. VARELA, M. BIANCHINI, Jiří MAYER, Daniela ŽÁČKOVÁ, Anežka KVETKOVÁ, Tomáš JURČEK, Ivana JEŽÍŠKOVÁ, ABP. LOPES, G. DUARTE, CA. SOUZA, J. MEDEIROS, TS. KIM, YS. YOO, KH. KIM, HW. LEE, MH. CHANG, SY. YI, S. ABELSON and D. KIM. Somatic mutations are frequently detected in CML patients before treatment-free remission (TFR) attempt with tyrosine kinase inhibitor (TKI) discontinuation but with uncertain predictive valu efor Tfr failure. In \textit{64th ASH Annual Meeting and Exposition, USA, New Orleans, prosinec 2022 in Blood}. 2022.

Detailed Information on Publication Record